Trovagene持有人提交发行最多163万股股票

TrovaGene (NASDAQ:TROV) shareholders have filed to offer up to 1,632,479 shares, issuable on exercise of warrants.

TROV is up 2.1% postmarket.

The company won't receive any proceeds from sales of the stock.

Selling stockholders include Sabby Volatility Warrant Master Fund and Lincoln Park Capital Fund, each holders of a 4.9% stake, and CVI Investments, holders of a 2.4% stake.